[ET Net News Agency, 18 January 2024] REMEGEN (09995) rose 9.7% to HK$26.65.
It hits an intra-day high of HK$26.8, and an intra-day low of HK$23.75. The total shares
traded was 5.78 million, with a value of HK$145.95m. The active buy/sell ratio is 53:47,
with net buying turnover of HK$8.78m. UBS accounts for greatest net responsive buying
turnover of HK$12.47m, with volume weighted average price of HK$25.026. CHINA INNOVATION
MARKET SER accounts for greatest net responsive selling turnover of HK$13.67m, with volume
weighted average price of HK$25.355.

Basic Information
=================

----------------------------------
Nominal 26.650 % Chg +9.67%
High 26.800 Low 23.750
Shares Tr 5.78m Turnover 145.95m
10-D SMA 31.510 %H.V 103.824
20-D SMA 33.188 VWAP 25.255
50-D SMA 38.733 RSI14 31.562
----------------------------------
Status: Active buy/sell ratio is 53:47, with net buying turnover of HK$8.78m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 26.65 +9.67
HUTCHMED (00013) 23.90 -0.21
GENSCRIPT BIO (01548) 17.36 +1.05
INNOVENT BIO (01801) 39.50 +2.07
JXR (01951) 2.55 -0.78
EVEREST MED-B (01952) 17.98 +1.24
KEYMED BIO-B (02162) 35.05 -5.27
WUXI BIO (02269) 29.15 +1.04
BEIGENE (06160) 100.00 +0.76
AKESO (09926) 45.50 +4.12
---------------------------------------------
(ed)